A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome

Pediatrics

Volumn 100, Issue 1, 1997, Pages 39-50

  Hudak, Mark L ^a,l   Martin, David J ^b   Egan, Edmund A ^a   Matteson, Elizabeth J ^a   Cummings, J ^a   Jung, August L ^c   Kimberlin, Lois V ^d   Auten, Richard L ^e   Rosenberg, Adam A ^f   Asselin, Jeanette M ^g   Belcastro, Marc R ^h   Donohue, Pamela K ⁱ   Hamm Jr , Charles R ^j   Jansen, Robert D ^k   Brody, Alan S ^b   Riddlesberger, Merchline M ^b   Montgomery, Paul ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d EVANSTON HOSPITAL   (United States)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g CHILDREN S HOSPITAL OAKLAND   (United States)

^h MIAMI VALLEY HOSPITAL   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SOUTH ALABAMA   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

Newborn; Pulmonary surfactant; Randomized clinical trial; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT;

AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SURVIVAL RATE;

AGE FACTORS; BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; DATA INTERPRETATION, STATISTICAL; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030794131     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.1.39     Document Type: Article

References (55)

1. Jobe A. Pulmonary surfactant therapy. N Engl J Med. 1993;328:861-868
2. Mercier C, Soll R. Clinical trials of natural surfactant extract in respiratory distress syndrome. Clin Perinatol 1993;20:711-735
3. Merritt T, Soll R, Hallman M. Overview of exogenous surfactant replacement therapy. J Intensive Care Med. 1993;8:205-228
4. Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis. 1987;136:1256-1275
5. Notter R. Physical chemistry and physiological activity of pulmonary surfactants. In: Shapiro D, Notter R, eds. Surfactant Replacement Therapy. New York, NY: Alan R Liss, Inc; 1989:19-70
6. Schurch S. Surface tension properties of surfactant. Clin Perinatol. 1993; 20:669-682
7. Cummings J, Holm B, Hudak M, Hudak B, Ferguson W, Egan E. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis. 1992;145: 999-1004
8. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J. 1993;6:971-977
9. Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis. 1992;145:24-30
10. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen C, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985;76: 145-153
11. Kattwinkel J, Bloom B, Delmore P. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks gestation. Pediatrics. 1993;92:90-98
12. Kwong M, Egan E, Notter R, Shapiro D. Double blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics. 1985;76:585-592
13. Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks gestation: a randomnized controlled trial of prophylaxis versus treatment. Pediatrics. 1991;87:377-386
14. Merritt TA, Hallman M, Berry C, et al. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr. 1991;118: 581-594
15. Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. N Engl J Med. 1991;324:865-871
16. Meinert C, Tonascia S. Clinical Trials: Design, Conduct, and Analysis. New York, NY: Oxford University Press; 1986
17. Exosurf Neonatal. (Colfosceril Palmitate, Cetyl Alcohol, Tyloxapol) for Intratracheal Suspension Package Insert. Research Triangle Park, NC: Burroughs Wellcome; 1990
18. Mizuno K, Ikegami M, Chen C, Ueda T, Jobe A. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. Pediatr Res. 1995;37:271-276
19. Glenski J, Marsh H, Hall R. Calculation of mean airway pressure during mechanical ventilation in neonates. Crit Care Med. 1984;12:642-644
20. Toce S, Farrell P, Leavitt L, Samuels D, Edwards D. Clinical and roentgenographic scoring systems for assessing bronchpulmonary dysplasia. Am J Dis Child. 1984;138:581-585
21. Papile L, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1500 gm. J Pediatr. 1978;92:529-534
22. Segerer H, vanGelder W, Angenent F, et al. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res. 1993;34:490-494
23. Ueda T, Ikegami M, Rider ED, Jobe AH. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol. 1994;76: 45-55
24. Berry D, Pramanik A, Philips J, et al. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group. J Pediatr. 1994;124: 294-301
25. Cummings JC, Holm BA, Nickerson PA, Ferguson WH, Egan EA. Preversus post-ventilatory surfactant treatment in surfactant-deficient preterm lambs. Reprod Fertil Dev. 1995;7:1333-1338
26. Corbet A, Bucciarelli R, Goldman S, et al. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J Pediatr. 1991;118: 277-284
27. Hoekstra R, Jackson J, Myers T, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics. 1991;88:10-18
28. Liechty E, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics. 1991;88:19-28
29. Long W, Thompson T, Sundell H, et al. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700-1350 gram infants with respiratory distress syndrome. J Pediatr. 1991;118:595-605
30. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 grams or more with respiratory distress syndrome. N Engl J Med. 1991;325:1696-1703
31. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics. 1988;82:683-691
32. Corbet A, Gerdes J, Long W, et al. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. J Pediatr. 1995; 126:969-978
33. Hudak ML, Farrell EE, Rosenberg AA, et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr. 1996;128:396-406
34. Ikegami M, Ueda T, Absolom D, Baxter C, Rider E, Jobe AH. Changes in exogenous surfactant in ventilated preterm lamb lungs. Am Rev Respir Dis. 1993;148:837-844
35. Egan EA. Surfactant phospholipid, not protein, concentration is the limiting factor in lung surfacant biophysical activity. Am Rev Respir Dis. 1992;145:A130
36. 2 in fetal, newborn, and adult sheep. Am J Physiol. 1982;242:H862-H866
37. 2 on brain blood flow and cardiac output in the newborn piglet. Pediatr Res. 1984;18:1132-1136
38. Nijima S, Shortland DB, Levene Ml, Evans DH. Transient hyperoxia and cerebral blood flow velocity in infants borm prematurely and at full term. Arch Dis Child. 1988;63:1126-1130
39. Volpe JJ. Intraventricular hemorrhage and brain injury in the premature infant. Clin Perinatol. 1989;16:361-386
40. Perlman JM, Volpe JJ. Episodes of apnea and bradycardia in the preterm newborn: impact on cerebral circulation. Pediatrics. 1985;76:333-338
41. Ramaekers VT, Casaer P, Daniels H. Cerebral hyperperfusion following episodes of bradycardia in the preterm infant. Early Human Dev. 1993; 34:199-208
42. Livera LN, Spencer SA, Thorniley MS, Wickramasinghe YABD, Rolfe P. Effects of hypoxaemia and bradycardia on neonatal cerebral haemodynamics. Arch Dis Child. 1991;66:376-380
43. Horbar JD, Soll RF, Schachinger H, et al. A European multicenter randomized controlled trial of single-dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr. 1990;149:416-423
44. Gunkel JH, Banks PLC. Surfactant therapy and intracranial hemorrhage: Review of the literature and results of new analyses. Pediatrics. 1993;92:775-786
45. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr. 1993;123:757-766
46. Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant in the treatment of neonatal respiratory distress syndrome. Pediatrics. 1996;97: 1-6
47. Calvert SA, Hoskins EM, Fong KW, Forsyth SC. Etiological factors associated with the development of periventricular leukomalacia. Acta Pediatr Scand. 1987;76:254-259
48. Low JA, Froese AF, Galbriath RS, Sauerbrei EE, McKinven JP, Karchmar EJ. The association of fetal and newborn metabolic acidosis with severe periventricular leukomalacia in the preterm newborn. Am J Obstet Gynecol. 1990;162:977-982
49. Trounce J, Shaw D, Levene M, Rutter N. Clinical risk factors and periventricular leucomalacia. Arch Dis Child. 1988;63:17-22
50. Graziani LJ, Spitzer AR, Mitchell DG, et al. Mechanical ventilation in preterm infants: neurosonographic and developmental studies. Pediatrics. 1992;90:515-522
51. Fujimoto S, Togari H, Yamaguchi N, Mizutani F, Suzuki S, Sobajima H. Hypocarbia and cystic periventricular leukomalacia in preterm infants. Arch Dis Child. 1994;71:F107-F110
52. Ikonen R, Janas M, Koivikko M, Kuusinen E. Hyperbilirubinemia, hypocarbia and periventricular leukomalacia in preterm infants: relationship to cerebral palsy. Acta Pediatr. 1992;81:802-807
53. Busija DW, Heistad DD, Marcus ML. Continuous measurement of cerebral blood flow in anesthetized cats and dogs. Am J Physiol. 1981; 241:H228-H234
54. 2 changes and visual evoked potentials in mechanically ventilated preterm infants. Acta Paediatr Scand. 1987;76:394-400
55. Vannucci RC, Towfighi J, Heitjan DF, Brucklacher RM. Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: an experiental study in the immature rat. Pediatrics. 1995;95:868-874